These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17290298)

  • 21. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling.
    Hirsch E; Costa C; Ciraolo E
    J Endocrinol; 2007 Aug; 194(2):243-56. PubMed ID: 17641274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAPKs and their relevance to arthritis and inflammation.
    Thalhamer T; McGrath MA; Harnett MM
    Rheumatology (Oxford); 2008 Apr; 47(4):409-14. PubMed ID: 18187523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why do phosphatidylinositol kinases have so many isoforms?
    Min SH; Abrams CS
    Biochem J; 2009 Sep; 423(1):e5-8. PubMed ID: 19740077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways.
    Montecucco F; Steffens S; Burger F; Da Costa A; Bianchi G; Bertolotto M; Mach F; Dallegri F; Ottonello L
    Cell Signal; 2008 Mar; 20(3):557-68. PubMed ID: 18164590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of phosphoinositide 3-kinase expression in health and disease.
    Kok K; Geering B; Vanhaesebroeck B
    Trends Biochem Sci; 2009 Mar; 34(3):115-27. PubMed ID: 19299143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis.
    Hawkins PT; Stephens LR
    Science; 2007 Oct; 318(5847):64-6. PubMed ID: 17916723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent findings on phosphoinositide-3 kinase in rheumatic diseases].
    Tamura N
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):8-13. PubMed ID: 22374437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.
    Elis W; Triantafellow E; Wolters NM; Sian KR; Caponigro G; Borawski J; Gaither LA; Murphy LO; Finan PM; Mackeigan JP
    Mol Cancer Res; 2008 Apr; 6(4):614-23. PubMed ID: 18403640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
    Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice.
    Takeda M; Ito W; Tanabe M; Ueki S; Kato H; Kihara J; Tanigai T; Chiba T; Yamaguchi K; Kayaba H; Imai Y; Okuyama K; Ohno I; Sasaki T; Chihara J
    J Allergy Clin Immunol; 2009 Apr; 123(4):805-12. PubMed ID: 19232703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?
    Grabiec AM; Tak PP; Reedquist KA
    Arthritis Res Ther; 2008; 10(5):226. PubMed ID: 18983693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
    Dil N; Marshall AJ
    Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3K signalling in inflammation.
    Hawkins PT; Stephens LR
    Biochim Biophys Acta; 2015 Jun; 1851(6):882-97. PubMed ID: 25514767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
    Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
    Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
    Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemically targeting the PI3K family.
    Knight ZA; Shokat KM
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):245-9. PubMed ID: 17371250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of class II phosphoinositide 3-kinase in cell signalling.
    Falasca M; Maffucci T
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):211-4. PubMed ID: 17371240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
    Herman S; Krönke G; Schett G
    Trends Mol Med; 2008 Jun; 14(6):245-53. PubMed ID: 18468489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation.
    Hallett JM; Leitch AE; Riley NA; Duffin R; Haslett C; Rossi AG
    Trends Pharmacol Sci; 2008 May; 29(5):250-7. PubMed ID: 18407359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.